Azacitidine

NDC 60505-6271 · Apotex Corp

Generic nameazacitidine

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)AZACITIDINE

Strength100 mg/1

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

60505-6271-1 — 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6271-1)

Billed under HCPCS

J9025 — Injection, azacitidine, 1 mg Medicare Part B payment limit (ASP + 6%): $0.27

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

31722-365 — Azacitidine, 43598-305 — Azacitidine, 43598-465 — Azacitidine, 43598-678 — AZACITIDINE, 43817-906 — Azacitidine, 55150-393 — AZACITIDINE, 58458-002 — Azacitidine, 59572-102 — azacitidine, 59572-730 — azacitidine, 59572-740 — azacitidine, 63323-771 — Azacitidine, 68001-313 — Azacitidine, 68001-527 — Azacitidine, 68001-620 — Azacitidine, 69539-112 — Azacitidine, 70069-857 — Azacitidine, 70121-1237 — AZACITIDINE, 71288-115 — Azacitidine, 71288-153 — Azacitidine, 72485-201 — azacitidine, +7 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources